ArticleActa neuropathologica communications2016

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.

Helga D Munch-Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.